Egypt approves Chinese Sinovac COVID-19 vaccine for emergency use sierraleonetimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sierraleonetimes.com Daily Mail and Mail on Sunday newspapers.
2021-04-27 12:36:28 GMT2021-04-27 20:36:28(Beijing Time) Xinhua English
CAIRO, April 27 (Xinhua) The Egyptian Drug Authority (EDA) approved the Chinese Sinovac COVID-19 vaccine for emergency use in Egypt, said the authority in a statement on its Facebook page on early Wednesday.
Mahmoud Yassin, head of EDA s Central Administration for Biological and Innovative Products, said the step is part of the state s efforts to control the spread of COVID-19 and provide the vaccines for all citizens.
He added that the EDA has authorized the license of using the vaccine after carrying out the required assessment based on the international and domestic conditions to ensure the effectiveness and quality of the vaccine.
Egyptian Drug Authority grants emergency license for China s CoronaVac arabnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arabnews.com Daily Mail and Mail on Sunday newspapers.
2021年04月26日 11時42分
Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields
Hong Kong, 2021年04月26日 - (JCN Newswire) - Scivita Medical Technology Co., Ltd. ( Scivita Medical ) today announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become one of the highest financing projects in the field of endoscope in China in recent years. The investment was jointly led by GL Ventures and Lilly Asia Ventures, with contribution from Matrix Partners China, Medtronic, Chengwei Capital and Shanghai Innochip Investment. The successful completion of the Series A funding round reflects the recognition of Scivita Medical in the field of endoscope and the expectation of its future development from the capital market and industrial strategic partners. Scivita Medical will strive to build the world s leading platfo
Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields
BriefingWire.com, 4/25/2021 - Scivita Medical Technology Co., Ltd. (Scivita Medical) today announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become one of the highest financing projects in the field of endoscope in China in recent years. The investment was jointly led by GL Ventures and Lilly Asia Ventures, with contribution from Matrix Partners China, Medtronic, Chengwei Capital and Shanghai Innochip Investment. The successful completion of the Series A funding round reflects the recognition of Scivita Medical in the field of endoscope and the expectation of its future development from the capital market and industrial strategic partners. Sci